CATHERINE ALLGRIM: Open Payments
NPI 1669808382 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 56 payments from 16 companies in 2025. Trend: 2023 $483 · 2024 $620 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $269 |
| Novo Nordisk Inc | 6 | $165 |
| AtriCure, Inc. | 6 | $142 |
| Kestra Medical Technology Services, Inc. | 1 | $135 |
| Abbott Laboratories | 3 | $127 |
| PFIZER INC. | 6 | $113 |
| Amgen Inc. | 6 | $95 |
| Philips North America LLC | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Corcept Therapeutics | 2 | $32 |
Products named: LEQVIO, Wegovy, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Assure WCD, VYNDAQEL, Repatha, AVEIR, Event.
Industry payments across SC — which companies pay providers there.
